In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK to sell Dr. Reddy's products in emerging markets

Executive Summary

In the same month it finalized plans to form a flu vaccine joint venture with China's Shenzhen Neptunus, GlaxoSmithKline is forging yet another deal in the emerging market space. This time Dr. Reddy's Laboratories will partner its branded generic drugs and pipeline with the Big Pharma in Africa, the Middle East, Asia Pacific (excluding India), and Latin America.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing
    • R&D and Marketing (Licensing)

Related Companies